Predicting Visual Acuity Deterioration and Radiation-Induced Toxicities after Brachytherapy for Choroidal Melanomas

Ruthenium-106 (Ru-106) brachytherapy is an established modality for eye-preserving treatment of choroidal melanoma. To achieve optimal treatment outcomes, there should be a balance between tumour control and the risk of healthy tissue toxicity. In this retrospective study, we examined normal tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Espensen, Charlotte A., Appelt, Ane L., Fog, Lotte S., Gothelf, Anita B., Thariat, Juliette, Kiilgaard, Jens F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721463/
https://www.ncbi.nlm.nih.gov/pubmed/31390850
http://dx.doi.org/10.3390/cancers11081124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721463/
https://www.ncbi.nlm.nih.gov/pubmed/31390850
http://dx.doi.org/10.3390/cancers11081124

Ejemplares similares